Allergy Therapeutics PLC
OTC:AGYTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Allergy Therapeutics PLC
OTC:AGYTF
|
UK |
|
Smith & Wesson Brands Inc
NASDAQ:SWBI
|
US |
|
A
|
Arctic Paper SA
WSE:ATC
|
PL |
|
Riot Blockchain Inc
NASDAQ:RIOT
|
US |
|
Sartorius AG
F:SRT4
|
DE |
|
Pyxis Tankers Inc
NASDAQ:PXS
|
GR |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
US |
|
Betsson AB
STO:BETS B
|
SE |
|
Melrose Industries PLC
LSE:MRO
|
UK |
|
Galapagos NV
AEX:GLPG
|
BE |
|
Figs Inc
NYSE:FIGS
|
US |
|
F
|
First Tractor Co Ltd
OTC:FIRRY
|
CN |
Wall St Price Targets
AGYTF Price Targets Summary
Allergy Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
AGYTF is 0.23 USD with a low forecast of 0.23 USD and a high forecast of 0.24 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AGYTF's stock price target?
Price Target
0.23
USD
According to Wall Street analysts, the average 1-year price target for
AGYTF is 0.23 USD with a low forecast of 0.23 USD and a high forecast of 0.24 USD.
What is the Revenue forecast for Allergy Therapeutics PLC?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is 18%.
What is the Gross Profit forecast for Allergy Therapeutics PLC?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 1 year is 26%.